On this page:
Promacta is a drug brand, brand.
Promacta a.k.a. Eltrombopag is a medication that has been developed for conditions that lead to thrombocytopenia. It is a small molecule agonist of the c-mpl receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the USA and European Union, it is being manufactured and marketed by GlaxoSmithKline under the trade name Promacta in the USA and will be marketed as Revolade in the EU. Eltrombopag was approved by the U.S. Food and Drug Administration on November 20, 2008. Eltrombopag received FDA breakthrough treatment designation in February 2014 for patients with aplastic anemia for which immunosuppression has not been successful. It has been shown to produce a trilineage hematopoesis in some patients with aplastic anemia, resulting in increased platelet counts, along with red and white blood cell counts.
Online dictionaries and encyclopedias with entries for Promacta
Click on a label to prioritize search results according to that topic:
Scrabble value of P3R1O1M3A1C3T1A1
The value of this 8-letter word is 14 points, but it's not an accepted word in the Official Scrabble Players Dictionary.
Anagrams of PROMACTA
What do you get if you rearrange the letters?
See also the blanagrams of Promacta!
Share this page
Go to the wordplay of Promacta for some fun with words!